Clinical characteristics, quality of life and prognosis of patients with chronic cardiorenal syndrome
Abstract
AIM. The aim of this study was to investigate clinical features, quality of life and prognosis in patients with chronic heart failure (CHF) and patients with CHF associated with chronic kidney disease (CKD). PATIENTS AND METHODS. 203 patients with CHF (130 males and 73 females, mean age was 61,8±9,6 years) were examined. CHF was defined according to the Russian guidelines for the diagnosis and treatment of chronic heart failure, 2012. CKD was defined according to the Russian guidelines for the diagnosis, prevention and treatment of CKD, 2012.Patients with CHF and CKD with GFR <60 mL/min/1,73 m2were included in group of chronic cardiorenal syndrome (CRS). Charlson comorbidity index, duration of hospitalization for a year follow up, clinical and psychological characteristics and quality of life in patients with CHF were estimated. RESULTS. 89 (44%) patients had chronic kidney disease (CKD) with glomerular filtration rate<60mL/min/1,73 m2 (chronic cardiorenal syndrome). Рatients with chronic cardiorenal syndrome had a higher comorbidity. Patients with CRS were hospitalized due to exacerbation CHF for year more often thanpatients without CRS. Рatients with chronic cardiorenal syndrome had expressed emotional discomfort, the presence of depressive, disadaptive trends, decreased of quality of life, both in the physical and the psychological aspects. CONCLUSION. Chronic kidney disease have a negative impact both on the clinical course and quality of life, psychological status and prognosis of patients with CHF. At the same time, patients with CRS have a high comorbidity, they are characterized by the presence of hypochondria and depression and low quality of life, which should be taken into account in the diagnosis and treatment of this group and assessment of prognosis.
About the Authors
E. V. Efremova
Ulyanovsk State University
Russian Federation
Russian Federation
A. M. Shutov
Ulyanovsk State University
Russian Federation
Russian Federation
References
1. Ronco C., Haapio C., House A.A. et al. Саrdiorenalsyndrome. J Am Coll Cardiol 2008; 52(19): 1527-1539
2. Шутов А.М., Серов В.А. Кардиоренальный и ренокардиальный синдромы. Нефрология 2009; 13(4): 59-63 [Shutov A.M., Serov V.A. Kardiorenal’nyj I renokardial’nyj sindromy. Nefrologija 2009; 13 (4): 59-63]
3. Серов В.А., Шутов А.М., Мензоров М.В. и др. Эпидемиология хронической болезни почек у больных с хронической сердечной недостаточностью. Нефрология 2010; 14(1): 50-55 [Serov V.A., Shutov A.M., Menzorov M.V. i dr. Epidemiologija hronicheskoj bolezni pochek u bol’nyh s hronicheskoj serdechnoj nedostatochnost’ju. Nefrologija 2010; 14(1): 50-55]
4. Aronow W.S., Ahn C., Mercando A.D. et al. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Card 2000; 86: 1142-1143.
5. Klein L., Massie B.M., Leimberger J.D. et al. Admission or changes in renal function during hospitalization for worsening heart failure predict post-discharge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008; 1 (l): 25-33.
6. Van Weel C., Schellevis F.G. Comorbidity and guidelines: conflicting interests. Lancet 2006; 367: 550-551
7. Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в Российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХА-О-ХСН). Сердечная недостаточность 2008; 5(1): 4-7. [Ageev F.T., Danieljan M.O., Mareev V. Ju I dr. Bol’nye s hronicheskoj serdechnoj nedostatochnost’ju v rossijskoj ambulatornoj praktike: osobennosti kontingenta, diagnostiki I lechenija (po materialam issledovanija JePOHA-O-HSN). Serdechnaja nedostatochnost' 2008; 5(1): 4-7]
8. Charlson M.E., Pompei P., Ales K.L., MacKenzieCRAnew methodofclassifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373-383
9. Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология 2012; 16 (1): 89-115 [Smirnov A.V., Shilov E.M., Dobronravov E.A. idr. Nacional’nye rekomendacii. Hronicheskaja bolezn’ pochek: osnovnye principy skrininga, diagnostiki, profilaktiki i podhody k lecheniju. Nefrologija 2012; 16 (1): 89-115]
10. Fortin M., Stewart M., Poitras M.E. et al. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med 2012; 10(2): 142-151.
11. Вёрткин А.Л., Скотников А.С. Коморбидность. Лечащий Врач 2013; 6: 66-68.[ Vjortkin A.L., Skotnikov A.S. Komorbidnost’. Lechashhij Vrach 2013; 6: 66-68]
12. Vincent M. van Deursen, Renato Urso, Cecile Laroche, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014; 16: 103-111
13. Tsang T.S., Barnes M.E., Gersh B.J. et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 2003; 42: 1199-1205
14. Макеева Е.Р., Шутов А.М., Серов В.А. Хроническая болезнь почек влияет на прогноз и стоимость стационарного лечения больных с хронической сердечной недостаточностью. Нефрология 2010; 14 (2): 51-55. [Makeeva E.R., Shutov A.M., Serov V.A. Hronicheskaja bolezn' pochek vlijaet na prognoz i stoimost' stacionarnogo lechenija bol'nyh s hronicheskoj serdechnoj nedostatochnost'ju. Nefrologija 2010; 14 (2): 51-55]
15. Hillege H.L., Nitsch D., Pfeffer M.A. et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation2006; 113 (5): 671-678
16. Lantelme P., Laurent S., Besnard C. Arterial stiffness is associated with left atrial size in hypertensive patients. Arch Cardiovasc Dis 2008; 101: 35-40
17. Kizer J.R., Bella J.N., Palmieri V. et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006; 151: 412-418
18. Watanabe H., Watanabe T., Sasaki S. et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009; 158(4): 629-636
19. Шутов А.М., Серов В.А., Гердт А.М. и др. Хроническая болезнь почек предрасполагает к фибрилляции предсердий у больных с хронической сердечной недостаточностью. Нефрология 2008; 12(4): 49-53. [Shutov A.M., Serov V.A., GerdtAMidr. Hronicheskajabolezn’ pochek predraspolagaet k fibrilljacii pred-serdij u bol’nyh s hronicheskoj serdechnoj nedostatochnost’ju. Nefrologija 2008; 12(4): 49-53]
20. Leon C.F,. Grady K.L., Eaton C. et al. Quality of life in a diverse population of patients with heart failure. J Cardiopulm Rehabil Prev 2009; 29(3): 171-178
Review
For citations:
Efremova E.V., Shutov A.M. Clinical characteristics, quality of life and prognosis of patients with chronic cardiorenal syndrome. Nephrology (Saint-Petersburg). 2015;19(2):63-67. (In Russ.)
Views:
571
Email this article 